e-learning
resources
Vienna 2003
Sunday 28.09.2003
Mechanisms of epithelial cell activation I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduced in vitro-proliferation rate of lung fibroblasts from patients with emphyseama
O. Holz, K. Paasch, I. Zühlke, E. Jaksztat, K. C. Müller, B. Feindt, L. Welker, D. Branscheid, M. Nakashima, K. D. Diemel, H. Magnussen, R. A. Jörres (Grosshansdorf, Germany)
Source:
Annual Congress 2003 - Mechanisms of epithelial cell activation I
Session:
Mechanisms of epithelial cell activation I
Session type:
Thematic Poster Session
Number:
591
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Holz, K. Paasch, I. Zühlke, E. Jaksztat, K. C. Müller, B. Feindt, L. Welker, D. Branscheid, M. Nakashima, K. D. Diemel, H. Magnussen, R. A. Jörres (Grosshansdorf, Germany). Reduced in vitro-proliferation rate of lung fibroblasts from patients with emphyseama. Eur Respir J 2003; 22: Suppl. 45, 591
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Differences of
in vitro
proliferation between skin and lung parenchymal fibroblasts in patients with emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 796s
Year: 2006
Reduced expression of CD44 on lung macrophages from patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Lung fibroblasts from COPD patients presented a reduced response to TGF-β1 for proliferation and elastin synthesis
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Patients with increased lung attenuation
Source: Annual Congress 2008 - Radiology Grand Round - an interactive session
Year: 2008
Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects.
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Decreased reactivity of the alveolar macrophages in relation to ICAM-1 expression after IFNγ stimulation in lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 276s
Year: 2002
Differences in the pattern of FEV1 and VC change after lung resection between lung cancer patients with limited and normal lung function
Source: Eur Respir J 2006; 28: Suppl. 50, 278s
Year: 2006
Reduced heart rate variability is associated with increased level of serum ICAM-1 in patients with sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Year: 2010
Decrease of skin reactivity to histamine in lung cancer patients
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
A comparison between total lung capacity and effective alveolar volume in patients with restrictive lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 180s
Year: 2005
Pi3kδ expression is increased in peripheral lung macrophages in COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Changes in resting metabolic rate in patients with severe emphysema after lung volume reduction surgery
Source: Eur Respir J 2003; 22: Suppl. 45, 369s
Year: 2003
DPP-4 is overexpressed in lung tissue from idiopathic pulmonary patients and activates lung fibroblasts
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis.
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Altered kinetics of TGFβ receptor II expression in pulmonary fibroblasts of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 224s
Year: 2005
Reduction of denitration-like activity in COPD lung tissue
Source: Eur Respir J 2004; 24: Suppl. 48, 99s
Year: 2004
Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture
Source: Eur Respir J 2004; 24 : 575-579
Year: 2004
Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Decreased lung attenuation
Source: Annual Congress 2008 - PG15 - High-resolution computed tomography of the lung: pattern recognition and role in diagnosis
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept